Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Sep;110(1):23–28. doi: 10.1111/j.1476-5381.1993.tb13766.x

Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.

J Leboeuf 1, M Basiez 1, R Massingham 1
PMCID: PMC2176014  PMID: 8220882

Abstract

1. The intravenous electrophysiological effects of a new antifibrillatory agent, Org 7797, were studied in closed chest anaesthetized dogs. Effects of fast sodium and slow calcium-mediated action potentials were also examined in guinea-pig isolated papillary muscle. 2. The major effects of a known antifibrillatory dose of Org 7797 (0.5 mg kg-1) were a protracted slowing of AV nodal conduction (for at least 20 min) and prolongation of the AV nodal functional refractory period. Conduction in the atria and His-Purkinje system (reflected by the St-A and HV intervals) were not significantly modified whilst ventricular conduction (reflected by the QRS interval) and the ventricular functional refractory period were only transiently prolonged. No other electrophysiological changes were seen. 3. A higher dose of Org 7797 (1.5 mg kg-1) slowed conduction at all levels of the myocardium (as evidenced by increases in the St-A, AH, HV and QRS intervals), slightly shortened cardiac repolarization (as assessed from JTc) and decreased Wenckebach rate. Atrial refractory periods were increased whereas effects on ventricular refractory periods were modest. 4. Neither heart rate nor sinus node recovery time were modified by either dose of Org 7797. 5. Org 7797, at a concentration (20 microM) which reduced Vmax of fast sodium-mediated action potentials in isolated papillary muscle by 83%, did not modify Vmax of slow calcium-mediated action potentials. It prolonged duration of the latter but did not modify that of the former. However, the plateau phase of both the 'fast' and especially the 'slow' action potentials was prolonged.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell J. K., Marshall R. J., Winslow E. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts. Br J Pharmacol. 1991 Oct;104(2):433–439. doi: 10.1111/j.1476-5381.1991.tb12447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell T. Differing electrophysiological effects of class IA, IB and IC antiarrhythmic drugs on guinea-pig sinoatrial node. Br J Pharmacol. 1987 Jun;91(2):395–401. doi: 10.1111/j.1476-5381.1987.tb10294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Connolly S. J., Kates R. E., Lebsack C. S., Echt D. S., Mason J. W., Winkle R. A. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia. Am J Cardiol. 1983 Dec 1;52(10):1208–1213. doi: 10.1016/0002-9149(83)90575-1. [DOI] [PubMed] [Google Scholar]
  4. Connolly S. J., Kates R. E., Lebsack C. S., Harrison D. C., Winkle R. A. Clinical pharmacology of propafenone. Circulation. 1983 Sep;68(3):589–596. doi: 10.1161/01.cir.68.3.589. [DOI] [PubMed] [Google Scholar]
  5. Costard-Jäckle A., Franz M. R. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. J Pharmacol Exp Ther. 1989 Oct;251(1):39–46. [PubMed] [Google Scholar]
  6. Fioretti P. M., Pozzoli M. M., Ilmer B., Salustri A., Cornel J. H., Reijs A. E., Krenning E. P., Reiber J. H., de Feyter P. J., Roelandt J. R. Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA. Eur Heart J. 1992 Feb;13(2):213–219. doi: 10.1093/oxfordjournals.eurheartj.a060149. [DOI] [PubMed] [Google Scholar]
  7. Fleckenstein A. Calcium antagonism in heart and vascular smooth muscle. Med Res Rev. 1985 Oct-Dec;5(4):395–425. doi: 10.1002/med.2610050402. [DOI] [PubMed] [Google Scholar]
  8. Follmer C. H., Colatsky T. J. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation. 1990 Jul;82(1):289–293. doi: 10.1161/01.cir.82.1.289. [DOI] [PubMed] [Google Scholar]
  9. Harrison D. C. Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol. 1985 Jul 1;56(1):185–187. doi: 10.1016/0002-9149(85)90591-0. [DOI] [PubMed] [Google Scholar]
  10. Hiraoka M., Sunami A., Fan Z., Sawanobori T. Multiple ionic mechanisms of early afterdepolarizations in isolated ventricular myocytes from guinea-pig hearts. Ann N Y Acad Sci. 1992 Jan 27;644:33–47. doi: 10.1111/j.1749-6632.1992.tb31000.x. [DOI] [PubMed] [Google Scholar]
  11. Hodess A. B., Follansbee W. P., Spear J. F., Moore E. N. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart. J Cardiovasc Pharmacol. 1979 Jul-Aug;1(4):427–439. doi: 10.1097/00005344-197907000-00005. [DOI] [PubMed] [Google Scholar]
  12. Janse M. J., Wilms-Schopman F., Opthof T. Mechanism of antifibrillatory action of Org 7797 in regionally ischemic pig heart. J Cardiovasc Pharmacol. 1990 Apr;15(4):633–643. doi: 10.1097/00005344-199004000-00017. [DOI] [PubMed] [Google Scholar]
  13. January C. T., Moscucci A. Cellular mechanisms of early afterdepolarizations. Ann N Y Acad Sci. 1992 Jan 27;644:23–32. doi: 10.1111/j.1749-6632.1992.tb30999.x. [DOI] [PubMed] [Google Scholar]
  14. Karagueuzian H. S., Katoh T., McCullen A., Mandel W. J., Peter T. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine. Am Heart J. 1984 Mar;107(3):418–424. doi: 10.1016/0002-8703(84)90080-2. [DOI] [PubMed] [Google Scholar]
  15. Kirchhof C., Wijffels M., Brugada J., Planellas J., Allessie M. Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol. 1991 Jan;17(1):116–124. doi: 10.1097/00005344-199101000-00017. [DOI] [PubMed] [Google Scholar]
  16. Leboeuf J., Lamar J. C., Massingham R., Ponsonnaille J. Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem. Br J Pharmacol. 1989 Dec;98(4):1351–1359. doi: 10.1111/j.1476-5381.1989.tb12684.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lynch J. J., DiCarlo L. A., Montgomery D. G., Lucchesi B. R. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. Pharmacology. 1987;35(4):181–193. doi: 10.1159/000138310. [DOI] [PubMed] [Google Scholar]
  18. Marrott P. K., Ruttley M. S., Winterbottam J. T., Muir J. R. A study of the acute electrophysiological and cardiovascular action of disopyramide in man. Eur J Cardiol. 1976 Sep;4(3):303–312. [PubMed] [Google Scholar]
  19. Narula O. S., Samet P., Javier R. P. Significance of the sinus-node recovery time. Circulation. 1972 Jan;45(1):140–158. doi: 10.1161/01.cir.45.1.140. [DOI] [PubMed] [Google Scholar]
  20. Noble D. Ionic mechanisms determining the timing of ventricular repolarization: significance for cardiac arrhythmias. Ann N Y Acad Sci. 1992 Jan 27;644:1–22. doi: 10.1111/j.1749-6632.1992.tb30998.x. [DOI] [PubMed] [Google Scholar]
  21. Ross D., Vohra J., Sloman J. G. Disopyramide in myocardial infarction. Lancet. 1978 Feb 11;1(8059):330–330. doi: 10.1016/s0140-6736(78)90103-4. [DOI] [PubMed] [Google Scholar]
  22. Schlepper M. Propafenone, a review of its profile. Eur Heart J. 1987 Mar;8 (Suppl A):27–32. doi: 10.1093/eurheartj/8.suppl_a.27. [DOI] [PubMed] [Google Scholar]
  23. Timour Q., Aupetit J. F., Loufoua-Moundanga J., Gerentes-Chassagne I., Kioueh I., Faucon G. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):645–651. doi: 10.1007/BF00184297. [DOI] [PubMed] [Google Scholar]
  24. Winslow E., Campbell J. K., Barron E., Marshall R. J., Muir A. W. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs. Br J Pharmacol. 1991 Dec;104(4):853–858. doi: 10.1111/j.1476-5381.1991.tb12517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Winslow E., Campbell J. K. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration. J Cardiovasc Pharmacol. 1991 Dec;18(6):911–917. doi: 10.1097/00005344-199112000-00019. [DOI] [PubMed] [Google Scholar]
  26. Winslow E., Martorana M., Bell P. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs. J Cardiovasc Pharmacol. 1989 Aug;14(2):205–212. doi: 10.1097/00005344-198908000-00004. [DOI] [PubMed] [Google Scholar]
  27. Winslow E., Mason R. Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts. J Cardiovasc Pharmacol. 1992 Mar;19(3):435–441. doi: 10.1097/00005344-199203000-00021. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES